1Hughes SE, Hall PA. Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res, 1993,27 : 1199-1203.
2Hasdai D, Barak V, Leibovitz E, et al. Serum basic fibroblast growth factor levels in patients with ischemic heart disease.Int J Cardiol, 1997, 59 : 133-138.
3Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coil Cardiol,1985,5:587-592.
4Casscells W, Speir E, Sasse J, et al. Isolation, characterization,and localization of heparin-binding growth factors in the heart.J Clin Invest,1990,85:433-441.
5Fujita M, lkemoto M, Kishishita M, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina.Circulation, 1996,94:610-613.
6Page E, Upshaw-Earley J, Goings G. Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules.Stretch-dependent effects. Circ Res, 1992, 71: 159-173.
7Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000, 87: 840-844.
8Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci, 2000,57:207-213.
2Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of out- come in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients. Circulation ,2000,101 (12) :2557-2567.
3Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment ofnon-ST-segrnent elevation acute cor- onary syndromes. J Am Coil Cardio1,2005,45 (6) :832-837.
4Woodworth S, Nayak D, W ilbert S, et al. Comparison of acute coronary syndromes inmen versuswomen > 70 years of age. Am J Cardiol, 2002,90 ( 10 ) : 1145 -1147.
5Howe M, Leidal A, Montgomery D. Bole of cigarette smoking and gender in acute coronary syndrome events. Am J Cardiol,2011, 108(10) : 1382-1386.
6Hu M, Tomlinson B. Gender-dependent associations of uric acid levels with a polymorphism in SLC2A9 in Han Chinese patients. Seand J Bheumatol,2012,41 (2) : 161-163.
7Feig DI,Mazzali M,Kang DH,et al. Serum uric acid:a risk factor and a target for treatment. J Am Soc Nephrol,2006,17 (4) :S69- S73.
8Wu Y, Wu H, Mueller C, et 81. Baseline platelet count and clini- cal outcome in acute coronary syndrome. Circ J,2012,76 (3): 704-711.
9Olivencia PL, Bueno CA, Soto BM. Acute coronary syndrome in women. Gender differences. Med Clin ( Barc), 2011,137 ( 14 ) : 623-630.
